Comparing Efficacy Between Robust and PTV Margin-based Optimizations for Interfractional Anatomical Variations in Prostate Tomotherapy

Overview

Journal In Vivo

Specialty Oncology

Date 2023 Dec 26

PMID 38148099

Authors

Takayuki Yagihashi

Tatsuya Inoue

Shintaro Shiba

Akihiro Yamano

Masashi Yamanaka

Naoki Sato

Kazumasa Inoue

Motoko Omura

Hironori Nagata

Affiliations

Soon will be listed here.

Abstract

Background/aim: Interfractional anatomical variations cause considerable differences between planned and actual radiotherapy doses. This study aimed to investigate the efficacy of robust and planning target volume (PTV) margin-based optimizations for the anatomical variations in helical tomotherapy for prostate cancer.

Patients And Methods: Ten patients underwent treatment-planning kilovolt computed tomography (kVCT) and daily megavolt computed tomography (MVCT). Two types of nominal plans, with a prescription of 60 Gy/20 fractions, were created using robust and PTV margin-based optimizations on kVCT for each patient. Subsequently, the daily estimated doses were recalculated using nominal plans, and all available MVCTs modified the daily patient-setup errors. Due to the difference in dose calculation accuracy between kVCT and MVCT, three scenarios with dose corrections of 1, 2, and 3% were considered in the recalculation process. The dosimetric metrics, including target coverage with the prescription dose, Paddick's conformity index, homogeneity index, and mean dose to the rectum, were analyzed.

Results: A dosimetric comparison of the nominal plans demonstrated that the robust plans had better dose conformity, lower target coverage, and dose homogeneity than the PTV plans. In the daily estimated doses of any dose-corrected scenario, the target coverage and dose sparing to the rectum in the robust plans were significantly higher than those in the PTV plans, whereas dose conformity and homogeneity were identical to those of the nominal case.

Conclusion: Robust optimization is recommended as it accounts for anatomical variations during treatment regarding target coverage in helical tomotherapy plans for prostate cancer.

References

Li H, Zhang X, Park P, Liu W, Chang J, Liao Z . Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. Radiother Oncol. 2015; 114(3):367-72. PMC: 4400219. DOI: 10.1016/j.radonc.2015.01.017. View

Shang H, Pu Y, Wang W, Dai Z, Jin F . Evaluation of plan quality and robustness of IMPT and helical IMRT for cervical cancer. Radiat Oncol. 2020; 15(1):34. PMC: 7020599. DOI: 10.1186/s13014-020-1483-x. View

Mackie T . History of tomotherapy. Phys Med Biol. 2006; 51(13):R427-53. DOI: 10.1088/0031-9155/51/13/R24. View

Yagihashi T, Inoue T, Shiba S, Yamano A, Minagawa Y, Omura M . Impact of delivery time factor on treatment time and plan quality in tomotherapy. Sci Rep. 2023; 13(1):12207. PMC: 10374581. DOI: 10.1038/s41598-023-39047-z. View

Langen K, Papanikolaou N, Balog J, Crilly R, Followill D, Goddu S . QA for helical tomotherapy: report of the AAPM Task Group 148. Med Phys. 2010; 37(9):4817-53. DOI: 10.1118/1.3462971. View

Tsunemine S, Ozawa S, Nakao M, Miura H, Saito A, Kawahara D . Influence of different air CT numbers for IVDT on the dose distribution in TomoTherapy MVCT. J Appl Clin Med Phys. 2022; 24(2):e13835. PMC: 9924119. DOI: 10.1002/acm2.13835. View

Brouwer C, Steenbakkers R, Langendijk J, Sijtsema N . Identifying patients who may benefit from adaptive radiotherapy: Does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help?. Radiother Oncol. 2015; 115(3):285-94. DOI: 10.1016/j.radonc.2015.05.018. View

Fredriksson A . A characterization of robust radiation therapy treatment planning methods-from expected value to worst case optimization. Med Phys. 2012; 39(8):5169-81. DOI: 10.1118/1.4737113. View

Roeske J, Forman J, Mesina C, He T, Pelizzari C, Fontenla E . Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 1995; 33(5):1321-9. DOI: 10.1016/0360-3016(95)00225-1. View

10.

Tegtmeier R, Ferris W, Bayouth J, Miller J, Culberson W . Characterization of imaging performance of a novel helical kVCT for use in image-guided and adaptive radiotherapy. J Appl Clin Med Phys. 2022; 23(6):e13648. PMC: 9194993. DOI: 10.1002/acm2.13648. View

11.

Yagihashi T, Inoue K, Nagata H, Yamanaka M, Yamano A, Suzuki S . Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer. J Appl Clin Med Phys. 2022; 24(4):e13881. PMC: 10113685. DOI: 10.1002/acm2.13881. View

12.

Zhang X, Rong Y, Morrill S, Fang J, Narayanasamy G, Galhardo E . Robust optimization in lung treatment plans accounting for geometric uncertainty. J Appl Clin Med Phys. 2018; 19(3):19-26. PMC: 5978970. DOI: 10.1002/acm2.12291. View

13.

Lim-Reinders S, Keller B, Al-Ward S, Sahgal A, Kim A . Online Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017; 99(4):994-1003. DOI: 10.1016/j.ijrobp.2017.04.023. View

14.

Sonke J, Aznar M, Rasch C . Adaptive Radiotherapy for Anatomical Changes. Semin Radiat Oncol. 2019; 29(3):245-257. DOI: 10.1016/j.semradonc.2019.02.007. View

15.

Lalonde A, Bobic M, Winey B, Verburg J, Sharp G, Paganetti H . Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation. Radiother Oncol. 2021; 159:39-47. PMC: 8205952. DOI: 10.1016/j.radonc.2021.03.008. View

16.

Wolf J, Nicholls J, Hunter P, Nguyen D, Keall P, Martin J . Dosimetric impact of intrafraction rotations in stereotactic prostate radiotherapy: A subset analysis of the TROG 15.01 SPARK trial. Radiother Oncol. 2019; 136:143-147. DOI: 10.1016/j.radonc.2019.04.013. View

17.

Nichol A, Brock K, Lockwood G, Moseley D, Rosewall T, Warde P . A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys. 2006; 67(1):48-56. DOI: 10.1016/j.ijrobp.2006.08.021. View

18.

Velten C, Goddard L, Jeong K, Garg M, Tome W . Clinical Assessment of a Novel Ring Gantry Linear Accelerator-Mounted Helical Fan-Beam kVCT System. Adv Radiat Oncol. 2022; 7(2):100862. PMC: 8749200. DOI: 10.1016/j.adro.2021.100862. View

19.

Ma T, Neylon J, Casado M, Sharma S, Sheng K, Low D . Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy. Radiother Oncol. 2022; 167:203-210. DOI: 10.1016/j.radonc.2021.12.037. View

20.

Paddick I, Lippitz B . A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006; 105 Suppl:194-201. DOI: 10.3171/sup.2006.105.7.194. View